Primary antiphospholipid syndrome: morphofunctional penile abnormalities with normal sperm analysis


Autoria(s): Rabelo-Junior, C. N.; Freire de Carvalho, J.; Lopes Gallinaro, A.; Bonfa, E.; Cocuzza, M.; Saito, O.; Silva, C. A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/09/2013

19/09/2013

2012

Resumo

Objective: To perform a global gonadal and sexual functions assessment in primary antiphospholipid syndrome (PAPS) patients. Methods: A cross-sectional study was conducted in 12 male PAPS patients and 20 healthy controls. They were assessed by demographic data, clinical features, systematic urological examination, sexual function, testicular ultrasound, seminal parameters according to the World Health Organization (WHO), seminal sperm antibodies, and hormone profile, including follicle stimulating hormone (FSH), luteinizing hormone (LH), morning total testosterone, and thyroid hormones. Results: The median of current age and age of spermarche were similar in PAPS patients and controls (37.5 vs. 32.4 years, p = 0.270, and 13.1 vs. 12.85 years, p = 0.224, respectively), with a higher frequency of erectile dysfunction in the former group (25% vs. 0%, p = 0.044). Further analysis of PAPS patients with and without previous arterial thrombosis demonstrated that the median penis circumference was significantly lower in PAPS with arterial thrombosis than in PAPS without this complication (8.1 [6-10] vs. 10.2 [10-11] cm, p = 0.007). In addition, the median penis circumference was significantly lower in PAPS patients with erectile dysfunction than in patients without this complication (7.5 [6-9.5] vs. 9.5 [7.5-11] cm, p = 0.039). Regarding seminal analysis, the median sperm concentration, sperm motility, and normal sperm forms by WHO guidelines were comparable in PAPS patients and controls (141.5 [33-575] vs. 120.06 [34.5-329] x 106/ml, p = 0.65; 61.29 [25-80] vs. 65.42 [43-82]%, p = 0.4; 21.12 [10-42.5] vs. 23.95 [10-45]%, p = 0.45, respectively), and none of them had oligo/azoospermia. No differences were observed between PAPS patients and controls regarding the frequency of antisperm antibodies, testicular volume by ultrasound, or hormone profile (FSH, LH, morning total testosterone, and thyroid hormone) (p > 0.05). Conclusions: Normal testicular function has been identified in PAPS patients, in spite of morphofunctional penile abnormalities. Previous arterial thrombosis may underlie penile anthropometry alteration. Lupus (2012) 21, 251-256.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2004/07832-2, 2005/56482-7]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPQ [3300665/2009-1, 301411/2009-3, 300248/2008-3]

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Federico Foundation

Federico Foundation

Identificador

LUPUS, LONDON, v. 21, n. 3, pp. 251-256, MAR, 2012

0961-2033

http://www.producao.usp.br/handle/BDPI/33500

10.1177/0961203311422715

http://dx.doi.org/10.1177/0961203311422715

Idioma(s)

eng

Publicador

SAGE PUBLICATIONS LTD

LONDON

Relação

LUPUS

Direitos

closedAccess

Copyright SAGE PUBLICATIONS LTD

Palavras-Chave #ANTIPHOSPHOLIPID SYNDROME #ANTISPERM ANTIBODIES #FERTILITY #PENILE #RHEUMATIC DISEASE #SPERM #SYSTEMIC-LUPUS-ERYTHEMATOSUS #RHEUMATIC-DISEASES #GONAD EVALUATION #FERTILITY #PREGNANCY #LENGTH #DRUGS #MALES #RHEUMATOLOGY
Tipo

article

original article

publishedVersion